141 related articles for article (PubMed ID: 6178872)
41. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.
Morelli E; Loon N; Meyer T; Peters W; Myers BD
Diabetes; 1990 Jan; 39(1):76-82. PubMed ID: 1698674
[TBL] [Abstract][Full Text] [Related]
42. Do large pores in the glomerular capillary wall account for albuminuria in nephrotic states?
Vuchkova J; Koltun M; Greive K; Comper WD
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F525-32. PubMed ID: 24990894
[TBL] [Abstract][Full Text] [Related]
43. Progression of overt nephropathy in non-insulin-dependent diabetes.
Myers BD; Nelson RG; Tan M; Beck GJ; Bennett PH; Knowler WC; Blouch K; Mitch WE
Kidney Int; 1995 Jun; 47(6):1781-9. PubMed ID: 7543961
[TBL] [Abstract][Full Text] [Related]
44. Early glomerular dysfunction in human renal allografts.
Zayas CF; Guasch A
Kidney Int; 2001 Nov; 60(5):1938-47. PubMed ID: 11703613
[TBL] [Abstract][Full Text] [Related]
45. Role for angiotensin II in an overt functional proteinuria.
Yoshioka T; Mitarai T; Kon V; Deen WM; Rennke HG; Ichikawa I
Kidney Int; 1986 Oct; 30(4):538-45. PubMed ID: 2431191
[TBL] [Abstract][Full Text] [Related]
46. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy.
Remuzzi A; Perticucci E; Ruggenenti P; Mosconi L; Limonta M; Remuzzi G
Kidney Int; 1991 Jun; 39(6):1267-73. PubMed ID: 1716713
[TBL] [Abstract][Full Text] [Related]
47. Normal glomerular permeability and its modification by minimal change nephrotic syndrmone.
Robson AM; Giangiacomo J; Kienstra RA; Naqvi ST; Ingelfinger JR
J Clin Invest; 1974 Nov; 54(5):1190-9. PubMed ID: 4417621
[TBL] [Abstract][Full Text] [Related]
48. Monitoring glomerular function in diabetic nephropathy. A prospective study.
Viberti GC; Bilous RW; Mackintosh D; Keen H
Am J Med; 1983 Feb; 74(2):256-64. PubMed ID: 6401924
[TBL] [Abstract][Full Text] [Related]
49. Correlation between histologic features and glomerular permeability in membranous nephropathy and immunoglobulin A nephropathy.
Ikegaya N; Nagase M; Honda N; Kumagai H; Hishida A
J Lab Clin Med; 1994 Jan; 123(1):94-101. PubMed ID: 7507157
[TBL] [Abstract][Full Text] [Related]
50. Proteinuria in diabetic kidney disease: a mechanistic viewpoint.
Jefferson JA; Shankland SJ; Pichler RH
Kidney Int; 2008 Jul; 74(1):22-36. PubMed ID: 18418356
[TBL] [Abstract][Full Text] [Related]
51. Glomerular permselectivity: barrier function based on discrimination of molecular size and charge.
Brenner BM; Hostetter TH; Humes HD
Am J Physiol; 1978 Jun; 234(6):F455-60. PubMed ID: 665772
[TBL] [Abstract][Full Text] [Related]
52. Glomerular permselectivity in proteinuric patients after kidney transplantation.
Oberbauer R; Haas M; Regele H; Barnas U; Schmidt A; Mayer G
J Clin Invest; 1995 Jul; 96(1):22-9. PubMed ID: 7615791
[TBL] [Abstract][Full Text] [Related]
53. Glomerular size and charge selectivity in insulin-dependent diabetes mellitus.
Deckert T; Feldt-Rasmussen B; Djurup R; Deckert M
Kidney Int; 1988 Jan; 33(1):100-6. PubMed ID: 3352157
[TBL] [Abstract][Full Text] [Related]
54. Effects of angiotensin II receptor blockade on remnant glomerular permselectivity.
Mayer G; Lafayette RA; Oliver J; Deen WM; Myers BD; Meyer TW
Kidney Int; 1993 Feb; 43(2):346-53. PubMed ID: 7680077
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
[TBL] [Abstract][Full Text] [Related]
56. Glomerular charge barrier and development of proteinuria in passive Heymann nephritis.
Christiansen RE; Kolmannskog O; Leh S; Iversen BM; Tenstad O
Kidney Blood Press Res; 2008; 31(3):203-9. PubMed ID: 18544954
[TBL] [Abstract][Full Text] [Related]
57. Glomerular charge alterations in human minimal change nephropathy.
Bridges CR; Myers BD; Brenner BM; Deen WM
Kidney Int; 1982 Dec; 22(6):677-84. PubMed ID: 6186837
[TBL] [Abstract][Full Text] [Related]
58. Selectivity of the glomerular filtration barrier in healthy and nephrotic humans.
Myers BD; Guasch A
Am J Nephrol; 1993; 13(5):311-7. PubMed ID: 8116683
[TBL] [Abstract][Full Text] [Related]
59. Fractional clearance of high molecular weight proteins in conscious rats using a continuous infusion method.
Burne MJ; Osicka TM; Comper WD
Kidney Int; 1999 Jan; 55(1):261-70. PubMed ID: 9893135
[TBL] [Abstract][Full Text] [Related]
60. Glomerular barrier function in advanced diabetic nephropathy.
Myers BD
Acta Endocrinol Suppl (Copenh); 1981; 242():36-8. PubMed ID: 6165209
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
